Findings on what compounds and supplements do in the body, with evidence strength, quote and paper.
- Passed: Handshake
- Passed: Tools listed
- Passed: Updated recently
Median latency 699 ms · Last checked
Explore
Evidence for your next connection.
Independent measurements of remote MCP servers. Every observation has a timestamp.
Read-only probesMCP server · Other
Live ClinicalTrials.gov oncology trial comparison around an asset, plus landscapes and CI briefings.
1 failed · 8 not measured
Median of successful probes over 7 days
Share of countable probes over 30 days, including daily rollups. Auth challenges are excluded.
Tool definitions returned by this server
Independent monitoring
Outdated check
Last connection measurement is over 24 hours old. Current availability is unknown.
Last checked| Test area | Passed | Failed | Unmeasured |
|---|---|---|---|
ConnectionCan a client connect and discover tools? | 5 | 0 | 0 |
Reliability & speedDoes it respond consistently and quickly? | 0 | 0 | 4 |
Access & authenticationWhat is required to use this server? | 1 | 0 | 2 |
Tool qualityAre the tool definitions usable by an agent? | 4 | 0 | 0 |
Publisher identityCan the publisher be traced to its source? | 3 | 1 | 2 |
Unmeasured means there is not enough evidence to decide. How these checks work
Start using Prognyx oncology intelligence
Choose your client, copy the configuration, then enable the server in your client’s MCP settings.
Run this command in your terminal, then restart Claude Code.
Claude Code
claude mcp add --transport http prognyx-oncology-intelligence https://www.prognyx.com/api/mcpCapabilities
Up to three interventional ClinicalTrials.gov studies matching an asset or target AND an oncology indication, side by side: sponsor, phase, status, declared arms, primary outcomes, last update, registry URL. Active studies first, then later phase; different sponsors where possible. Use a target (e.g. "KIF18A", "B7-H3") rather than one drug name to see other programmes.
DiscoveredPrognyx oncology competitive-intelligence briefings (each claim linked to a primary source) matching a drug, company, target or indication, newest first, with URL, date and summary.
DiscoveredLive landscape for a target, asset, company, indication or NCT number: total and active study counts, leading sponsors, phase mix, the most recently updated studies with URLs, and related Prognyx briefings. Counts for phases and sponsors come from a recent sample, stated in the result.
DiscoveredRecent measurements
| Checked | Result | Response | Tools |
|---|---|---|---|
| Connected | 2128 ms | 3 |